WebGEPTI: Grupo Español de Trombocitopenia Inmune WebHematología (PETHEMA) se propon unas guías para el tratamiento de la LMA eusier pacientes n de edad ≥ a 65 años y/o no elegibles para recibir quimioterapia intensiva …
GUIA PARA EL DIAGNOSTICO Y TRATAMIENTO DE LA …
WebMar 22, 2024 · Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL. Alberto Marín-Sánchez 1, Gonzalo Martínez-Fernández 2, Irene Gómez-Catalán 1, Mari Carmen Montoya-Morcillo 1, Jesús Lorenzo Algarra 1, Ángela Ibañez García 1, Francisco Hernández-Fernández 3 … WebWe present the results of treatment of Philadelphia chromosome-negative (Ph-) ALL patients over 55 yr treated in the PETHEMA ALL-96 trial. Patients and methods: From 1996 to 2006, 33 patients > or = 55 yr with Ph- ALL were included. Induction therapy was vincristine, daunorubicin, prednisone, asparaginase, and cyclophosphamide over 5 weeks. old ship inn brighton
Llevamos la investigación en la sangre. Fundación Pethema
WebFeb 15, 2011 · PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. WebMay 5, 2011 · All-trans-retinoic acid (ATRA) has greatly modified the prognosis of acute promyelocytic leukemia; however, the role of maintenance in patients in molecular complete remission after consolidation treatment is still debated.From July 1993 to May 2000, 807 genetically proven newly diagnosed acute promyelocytic leukemia patients received … WebEsta guía, desarrollada por el Grupo Español de Mieloma-Programa Español de Tratamientos en Hematología (GEM-PETHEMA) y avalada por la Sociedad Española de Hematología y Hemotera- pia (SEHH), pretende reflejar la situación actual del diagnóstico y tratamiento de los pacientes con MM en España. isabella with her hair down tpn